CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Total Revenues | $ 48,194 | $ 48,300 | $ 45,006 | ||
| Cost of products sold | [1] | 13,936 | 13,968 | 10,693 | |
| Selling, general and administrative | 7,267 | 8,414 | 7,772 | ||
| Research and development | 9,951 | 11,159 | 9,299 | ||
| Acquired IPRD | 3,721 | 13,373 | 913 | ||
| Amortization of acquired intangible assets | 3,317 | 8,872 | 9,047 | ||
| Other (income)/expense, net | 674 | 893 | (1,158) | ||
| Total Expenses | 38,866 | 56,679 | 36,566 | ||
| Earnings/(Loss) before income taxes | 9,328 | (8,379) | 8,440 | ||
| Income tax provision | 2,272 | 554 | 400 | ||
| Net earnings/(loss) | 7,055 | (8,933) | 8,040 | ||
| Noncontrolling Interest | 2 | 15 | 15 | ||
| Net earnings/(loss) attributable to BMS | $ 7,054 | $ (8,948) | $ 8,025 | ||
| Earnings/(Loss) per common share: | |||||
| Basic (in dollars per share) | $ 3.47 | $ (4.41) | $ 3.88 | ||
| Diluted (in dollars per share) | $ 3.46 | $ (4.41) | $ 3.86 | ||
| Net product sales | |||||
| Total Revenues | $ 46,756 | $ 46,778 | $ 43,778 | ||
| Alliance and other revenues | |||||
| Total Revenues | $ 1,438 | $ 1,522 | $ 1,228 | ||
| |||||
| X | ||||||||||
- Definition Acquired IPRD No definition available.
|
| X | ||||||||||
- Definition Amortization of Acquired Intangible Assets No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|